文献速递瓣膜外科

重新审视50岁以下患者主动脉瓣人工瓣膜选择:AUTHEARTVISIT研究10年结果

Revisiting aortic valve prosthesis choice in patients younger than 50 years: 10 years results of the AUTHEARTVISIT study.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

这项基于人群的队列研究分析奥地利2010至2020年991例50岁以下行主动脉瓣置换术患者,比较生物瓣与机械瓣的中期结局。生物瓣组再手术风险显著升高(HR=2.770),无再手术生存率降低(HR=1.560),但两组总生存无显著差异(P=0.352)。

要点

  • 50岁以下主动脉瓣置换患者中,生物瓣组再手术风险显著高于机械瓣组(HR=2.770,95%CI 1.076-2.262)。
  • 生物瓣组无再手术生存率显著降低(HR=1.560,95%CI 1.076-2.262,P=0.019)。
  • 两组总生存无显著差异(P=0.352),中位随访6.2年。

核心结论

  • 50岁以下患者行主动脉瓣置换时,与机械瓣相比,生物瓣植入与显著更高的再手术率和降低的无再手术生存率相关,但未观察到总生存差异。
  • 作者指出需长期随访评估显著较低的再手术率是否转化为持续改善的长期生存。

研究设计与样本

  • 基于人群的队列研究,分析奥地利主要社会保险机构2010至2020年患者数据,并与国家健康数据进行患者层面记录链接。
  • 共纳入991例50岁以下行主动脉瓣置换术患者。

主要发现

  • 中位随访6.2年,多变量Cox回归显示两组总生存无显著差异(P=0.352)。
  • 生物瓣组无再手术生存率降低(HR=1.560,95%CI 1.076-2.262,P=0.019),再手术风险升高(HR=2.770,95%CI 1.402-5.472,P=0.003)。
  • 两组再手术后估计死亡概率2年为0.23(CL 0.08-0.35),10年为0.34(CL 0.06-0.53)。
  • 其他结局(心肌梗死、心力衰竭、栓塞性卒中或脑出血、非脑出血性出血及主要不良心脏事件)两组间无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This population-based cohort study investigated mid-term outcome after surgical aortic valve replacement with a bioprosthetic or mechanical valve prosthesis in patients aged <50 years in a European social welfare state. METHODS: We analysed patient data from the main social insurance carriers in Austria (2010-2020). Subsequent patient-level record linkage with national health data provided patient characteristics and clinical outcome. Survival, reoperation, myocardial infarction, heart failure, embolic stroke or intracerebral haemorrhage, bleeding other than intracerebral haemorrhage and major adverse cardiac events were evaluated as outcomes. RESULTS: A total of 991 patients were analysed. Regarding demographics, no major differences between groups were observed. Multivariable Cox regression revealed no significant difference in overall survival (P = 0.352) with a median follow-up time of 6.2 years. Reoperation-free survival was decreased (hazard ratio = 1.560 [95% CI: 1.076-2.262], P = 0.019) and the risk for reoperation was increased (hazard ratio = 2.770 [95% CI: 1.402-5.472], P = 0.003) in patients who received bioprostheses. Estimated probability of death after reoperation was 0.23 (CL: 0.08-0.35) after 2 years and 0.34 (CL: 0.06-0.53) after 10 years over both groups. Regarding further outcomes, no significant differences between the two groups were observed. CONCLUSIONS: In patients below 50 years of age receiving aortic valve replacement, implantation of bioprostheses when compared to mechanical heart valve prostheses was associated with a significantly higher rate of reoperations and reduced reoperation-free survival. Nevertheless, we could not observe a difference in overall survival. However, long-term follow-up has to evaluate that a significantly lower rate of reoperations may translate in consistently improved long-term survival.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Traxler D, Krotka P, Reichardt B, et al. Revisiting aortic valve prosthesis choice in patients younger than 50 years: 10 years results of the AUTHEARTVISIT study. Eur J Cardiothorac Surg. 2024. PMID: 37756697. doi:10.1093/ejcts/ezad308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。